bluebird bio, Inc. (BLUE)
Terms and Conditions
JD.com reports a 17% YoY increase in Q1 revenue
JD | 4.15%
Warby Parker reported its Q1 results: here are the notable figures
These 3 Stocks Are Resilient In The Current Bear Market.
Is Ark Invest Wrong About These 2 Stocks?
What Really Happened to Palantir Stock? A Look at Palantir's Earnings Report
Another Red Week For The Market
Cathie Woods Is In A Mess Right Now
BLUE | bluebird bio, Inc.
One Biotech Stock to Hold; Another to Dump Right Now
Biotech stocks have been successful in going public without revenues because the story of a pharmaceutical firm gaining FDA approval for a new drug is attractive to many investors.
By Precious Njoku |
1 week ago